The role of fibroblast growth factor-23 in chronic kidney disease-mineral and bone disorder

The role of fibroblast growth factor-23 in chronic kidney disease-mineral and bone disorder

Fibroblast growth factor-23 (FGF23) was initially identified as the causative factor of autosomal dominant hypophosphatemic rickets. Further studies confirmed that FGF23 is predominantly expressed in the osteocytes and osteoblasts of bone and that circulating FGF23 acts on the kidney to inhibit rena...

Full description

Bibliographic Details
Main Author: Mirza, Majd A. I.
Format: Doctoral Thesis
Language:English
Published: Uppsala universitet, Medicin 2010
Subjects:
FGF23
FGF-23
CKD
CKD-MBD
cardiovascular disease
vascular function
atherosclerosis
hypertrophy
LVMI
LVH
fractures
bone
fat mass
obesity
apolipoproteins
cholesterol
lipids
Kidney diseases
Njursjukdomar
Cardiovascular medicine
Kardiovaskulär medicin
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-130339
http://nbn-resolving.de/urn:isbn:978-91-554-7883-4

Internet

http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-130339
http://nbn-resolving.de/urn:isbn:978-91-554-7883-4

Similar Items